focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
its hard to say dave my guess would be a sell and like researcher mentioned could be jupiter offloading. i dont think theyres been enough volume to get rid of that volume in normal market so looks like theres a buyer at this level and happy to snap them up at 44ish pence. possibly the continous 10k trades are getting mopped up from the mystery buyer also. without the big buyer in the background the sp would of already collasped with the selling pressure. one things for sure if when the selling pressure stocks this will bounce fast.
jupiter had around 17.2M shares left around sept time and if they are indeed the ones selling then i expect a holdings RNS shortly. might even give an indication whos buying off them.
its hard to say dave my guess would be a sell and like researcher mentioned could be jupiter offloading. i dont think theyres been enough volume to get rid of that volume in normal market so looks like theres a buyer at this level and happy to snap them up at 44ish pence. possibly the continous 10k trades are getting mopped up from the mystery buyer also. without the big buyer in the background the sp would of already collasped with the selling pressure. one things for sure if when the selling pressure stocks this will bounce fast.
jupiter had around 17.2M shares left around sept time and if they are indeed the ones selling then i expect a holdings RNS shortly. might even give an indication whos buying off them.
late trade of £1M popping up after hours. wonder if thats the order finally completed. i have been noticing the several 10k trades popping up last week or two several times a day and thought there might of been a big trade being worked into the background. there sure was!
my thougts exactly john. so couldnt help myself grabbed another 2k this morning. i see no reason why AGL cant gain FDA approval next year. would like it to run smoothly and gain acceptance early in the year (or Q2 as stated) but if there are any delays im more than happy to hold... after being in/out of AGL since 2013 whats another few months holding for the payday all LTHs have been eyeing up since FDA on parsortix was first mentioned many years ago lol.
-fully funded no placements coming up.
- talking with potential partners (mentioned breifly in news),
-great management who havent viewed AGL as a lifestyle company,
-growing need for product in a billion $ industry who will soon be viewed as the gold standard,
-high priced option price many multiples of todays SP for BOD based on future milestones and achivements
-SP is at the 52 week low so plenty of room to go with minimum risk vs reward
- possible buyout from a big pharma player who would likely over upwards of £2 (my opinion we will see that price before buyouts are considered)
whats not to like?.... current sp yup... could be better but AGL has never been a quick return its a slow burner with solid foundations set for long term growth. plenty of aim shares out there for a fast buck but this will soon be on everyones radar, maybe needs the FDA approval news but it will come.
although the project has been fully shelved and costs wiped off the books it took WSG years to finalise the contract and get it signed. this would of involved background due diligence at the highest of level when involved iranian goverbments and UK governments. i would expect all that hard work hasnt completely just vanished never to return. although iran could of started the whole process again but financing would be difficult from any company around the world with the sanctions. WSG already had these in place and im sure they can once again gain the support of finance lenders and process with it. all it would take is to sit down and renegotiate the deal once again... either on same terms as previous or comepletely new ones. i still think theres a chance it being resurrected
https://www.google.co.uk/amp/s/www.aljazeera.com/amp/news/2020/11/8/what-will-a-biden-presidency-mean-for-iran
i would be very surprised if the iran airport contract wasnt being handshaked behind closed doors awaiting on the reversal of santions from US governments. time will tell if biden does want to reverse the damage trump did or if its all just smoke and mirrors! we will see. WSG sp will surely react to this news when its made public but question is... do you jump in before and wait or sit on the sidelines and wait!
on the charts were bang on a long term support area of 45p. hopefully this will be an area where buyers take up a position. i will be ;)
https://www.screencast.com/t/RxqL73abrn
i wouldnt be surprised if these placing shares were forward sold from the 50-55p swing we had at the start of last month. that would give placee's their 20% flip and now mm's balancing the books hence drop towards 46p even after decent FDA acceptance news along with other postive news.
like what monkshood mentioned. they should of had around £6-8M in cash so that was several months before they had to raise again. possibly obtaining a safety net just incase theres any delays in FDA approval and sp getting hit. now they have plenty of cash (after placing) and able to comfortably wait on fda approval but can get into discussions with partners so they can close the contracts ater approval.
revenue down 39% which is never good reading but understandable considering covid restrictions on cancer research facilities. although maintaining a 75% margin is still very good. and when the sales start coming in after FDA approval that 75% margin will bring in some serious cash.
last placing before FDA approval then start the growth phase (until buy out anyway!!). more positive news regarding clinical lab's or 'commerical expansion' will boost the SP hopefully before the march-may timeframe on FDA approval.
bod have stated they expect clearance within 6 months but the bottom line its down to FDA and when they give clearance. there might be some delays due to current pandemic but all going well possible clearance before march 2021.
hey dave nice to see the LTHs still holding over the years!
about a possible listing on nasdaq. they might want a duel listing and if thats the case nothing will happen to your shares you'll be free to sell/buy whenver you want. they might decide to move from aim and be solely listed on nasdaq but i cant see that happening unless they deem it as a expensense not worth it and cost cutting but i cant see that to begin with. maybe future growth but could be a while away. if they do leave aim you will still have your stock whoch would mean you can hold onto it and sell after the move if your broker accepts overseas trades. would need to check your broker first, im sure all the big brokers HL, IG, plus500 etc will all do overseas trading but may occur a small charge from broker. its either that or sell up before nasdaq listing and aim cancellation (if that happens)
with a dilutition theyre should be an IPO if listing onto nasdaq but should get a good valuation depending how well parsortix takes off so i wouldnt worry too much about dilution as it will bring new investors who in turn should boost the sp value.
if a large pharama buys us out we should get a price for all the uk shares for example if they offered £5 a share then as long as were listing in aim market will get that price. as for duel listings and takeovers im not too sure about the hoops someone would need to jump through to get that across the line. im sure they would have a figure of and just be converted to uk £s if figure buy out was in $ from a usa pharma company
nice update on progress ... i liked the part..
"The Company has also received several licensing enquiries from potential international partners in respect of additional CoalSwitch™ plants since the award of the Permit."
lets hope some RNS's come our way and surprises us with new licensing deals. possibly asia? been very quiet on those partnerships from the last year or two. might get them back in the picture
manU
http://www.aastocks.com/en/stocks/quote/detail-quote.aspx?symbol=01156
within the 3 weeks on HKex it hasnt gone the way weve all hoped.
sp down around 55% on ipo price.
sp is down 65% from listing price of HK$1.23 on first day of trading
sp is down 68-69% from peak of HK$1.38 on first day of trading.
sp finished on aim around 8p... now around 4.3p
its safe to say that the move over to HKex hasnt benefitted any shareholders yet. and with the increased possible selling pressure when uk holders are free to sell shares i dont see any climb back up to ipo price any time soon. possibly need to wait for results in sept time or any surprise contracts until then.
not good CNEL.... but theres bugger all we can do.
yup mines is gone too. still showing CNEL and shares i have but no.value added to portfolio. its a shame the bod did take the opertunity for a fresh start on HKex and releasing an operational update within the first couple of days, explaining current projects, breif update on current revenue/ cash and order book etc. a littlw update to wet the appitite of new investors. we were always in the dark on aim with new contract wins etc but just thought it would of been different. aim was a bit of a shambles until the big rise before cancellation. HKex was meant to be different, i know its still way too early to judge but up to now theres nothing changed compared to being listed on aim, shareholders kept in the dark, no PR to boost value of sp where the bod have said many times its under valued. i know the results are round the corner in a few weeks time around sept time, but i dont want to wait until then to only break even on my invested for it to dip right after just like the cycle on aim.
guess its a hold and wait then!!